In previous studies, Guo and his colleagues provided evidence that the in vitro TNBC cell-ICAM1 antibody binding force on live cells correlated with the in vivo tumor accumulation and therapeutic efficacy of ICAM1 antibody-directed liposomes (25). Here, ICAM1 is linked to neoplasm.